The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells

BACKGROUND: Neuroendocrine (NE) differentiation represents a common feature of prostate cancer and is associated with accelerated disease progression and poor clinical outcome. Nowadays, there is no treatment for this aggressive form of prostate cancer. The aim of this study was to determine the inf...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Prostate Cancer Prostatic Dis
Auteurs principaux: Morell, C, Bort, A, Vara, D, Ramos-Torres, A, Rodríguez-Henche, N, Díaz-Laviada, I
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5411672/
https://ncbi.nlm.nih.gov/pubmed/27324222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires